According to Sun Pharmaceutical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.26104. At the end of 2023 the company had a P/S ratio of 6.43.
Year | P/S ratio | Change |
---|---|---|
2023 | 6.43 | 16.41% |
2022 | 5.53 | 2.45% |
2021 | 5.39 | 22.47% |
2020 | 4.40 | 35.2% |
2019 | 3.26 | -9.29% |
2018 | 3.59 | -32.04% |
2017 | 5.28 | 8.81% |
2016 | 4.86 | -32.84% |
2015 | 7.23 | 10.04% |
2014 | 6.57 | -13.22% |
2013 | 7.57 | 6.58% |
2012 | 7.11 |